Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA asks Amgen, J&J to discuss anemia drug risks
FDA asks Amgen, J&J to discuss anemia drug risks
FDA asks Amgen, J&J to discuss anemia drug risks
Submitted by
admin
on February 16, 2010 - 10:23am
Source:
Yahoo/AP
News Tags:
JNJ
Amgen
FDA
anemia
Aranesp
Procrit
Epogen
Headline:
FDA asks Amgen, J&J to discuss anemia drug risks
Do Not Allow Advertisers to Use My Personal information
